Many of the world’s most exciting businesses are not yet listed on a stock exchange, but that doesn’t mean investors can’t get exposure to this...

It may not have gone negative yet but the yield curve – as measured by the difference in the yield available on 10-year and two-year...

Wouldn’t it be nice to have an investment portfolio that paid you a regular stream of cash so you can get on with your life...

One share, one vote remains one of the bedrocks of UK stock ownership yet the debate on so-called dual-class listings could heat up once again...

Our top picks of the year have got off to a great start with the portfolio up 14.1% versus 7.9% from the wider market. 

...

Stock markets around the world have bounced back in 2019 with positive gains in every single major market. This is a great outcome given how...

Investors in foods-to-fashion conglomerate Associated British Foods (ABF) should note a new risk to earnings for its sugar business after industry peer Suedzucker...

AstraZeneca (AZN) £61.67

Loss to date: 2.1%

Original entry point: Buy at £63.00, 15 November 2018

AstraZeneca’s (...

I’m researching my options before going into drawdown and came across some research that suggests charges can range between 0.4% and 1.6%. Is a price...

A disappointing share price showing in the last 12 months has created an excellent opportunity to buy FTSE 100 insurance business Prudential (PRU) ahead...